These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1314826)

  • 1. Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action.
    Cama A; Quon MJ; de la Luz Sierra M; Taylor SI
    J Biol Chem; 1992 Apr; 267(12):8383-9. PubMed ID: 1314826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of glutamic acid for alanine 1135 in the putative "catalytic loop" of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity.
    Cama A; de la Luz Sierra M; Quon MJ; Ottini L; Gorden P; Taylor SI
    J Biol Chem; 1993 Apr; 268(11):8060-9. PubMed ID: 8096518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor.
    Levy-Toledano R; Caro LH; Accili D; Taylor SI
    EMBO J; 1994 Feb; 13(4):835-42. PubMed ID: 8112298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman.
    Cama A; de la Luz Sierra M; Ottini L; Kadowaki T; Gorden P; Imperato-McGinley J; Taylor SI
    J Clin Endocrinol Metab; 1991 Oct; 73(4):894-901. PubMed ID: 1890161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine.
    Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y
    J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function.
    Wilden PA; Kahn CR; Siddle K; White MF
    J Biol Chem; 1992 Aug; 267(23):16660-8. PubMed ID: 1322912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
    McClain DA; Maegawa H; Lee J; Dull TJ; Ulrich A; Olefsky JM
    J Biol Chem; 1987 Oct; 262(30):14663-71. PubMed ID: 3312193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A domain of the insulin receptor required for endocytosis in rat fibroblasts.
    Thies RS; Webster NJ; McClain DA
    J Biol Chem; 1990 Jun; 265(17):10132-7. PubMed ID: 2161833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of C-terminal 113 amino acids impairs processing and internalization of human insulin receptor: comparison of receptors expressed in CHO and NIH-3T3 cells.
    Levy-Toledano R; Accili D; Taylor SI
    Biochim Biophys Acta; 1993 Dec; 1220(1):1-14. PubMed ID: 8268238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies.
    Wilden PA; Siddle K; Haring E; Backer JM; White MF; Kahn CR
    J Biol Chem; 1992 Jul; 267(19):13719-27. PubMed ID: 1320027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation.
    Maegawa H; Olefsky JM; Thies S; Boyd D; Ullrich A; McClain DA
    J Biol Chem; 1988 Sep; 263(25):12629-37. PubMed ID: 2970462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor.
    Kishimoto M; Hashiramoto M; Yonezawa K; Shii K; Kazumi T; Kasuga M
    J Biol Chem; 1994 Apr; 269(15):11349-55. PubMed ID: 7512563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.
    Chou CK; Dull TJ; Russell DS; Gherzi R; Lebwohl D; Ullrich A; Rosen OM
    J Biol Chem; 1987 Feb; 262(4):1842-7. PubMed ID: 3100537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies mimic insulin activation of ribosomal protein S6 kinase without activation of insulin receptor tyrosine kinase. Studies in cells transfected with normal and mutant human insulin receptors.
    Sung CK; Maddux BA; Hawley DM; Goldfine ID
    J Biol Chem; 1989 Nov; 264(32):18951-9. PubMed ID: 2553727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the extracellular domain of the insulin receptor impairs the ability of insulin to stimulate receptor autophosphorylation.
    Accili D; Mosthaf L; Ullrich A; Taylor SI
    J Biol Chem; 1991 Jan; 266(1):434-9. PubMed ID: 1845971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action.
    Formisano P; Sohn KJ; Miele C; Di Finizio B; Petruzziello A; Riccardi G; Beguinot L; Beguinot F
    J Biol Chem; 1993 Mar; 268(7):5241-8. PubMed ID: 8383132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function.
    Blakesley VA; Kato H; Roberts CT; LeRoith D
    J Biol Chem; 1995 Feb; 270(6):2764-9. PubMed ID: 7852347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase-defective insulin receptors undergo decreased endocytosis but do not affect internalization of normal endogenous insulin receptors.
    Grako KA; Olefsky JM; McClain DA
    Endocrinology; 1992 Jun; 130(6):3441-52. PubMed ID: 1317784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles.
    Kusari J; Takata Y; Hatada E; Freidenberg G; Kolterman O; Olefsky JM
    J Biol Chem; 1991 Mar; 266(8):5260-7. PubMed ID: 2002058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.